Patent Owner Loses Everything at PTAB

In Mati Therapeutics, Inc. v. Ocular Therapeutix, Inc., the Federal Circuit issued a Rule 36 opinion affirming the Patent Trial and Appeal Board’s PTAB’s Final Written Decision FWD holding all challenged claims unpatentable.

Related Keywords

United States ,Teva Pharms ,Toro Co ,Institution Decision ,Ocular Therapeutix Inc ,United States Inc ,Foxconn Intl Inc ,Johnson Johnston Assocs Inc ,Mati Therapeutics Inc ,Hindus Inc ,See Pfizer Inc ,Co Inc ,Mati Therapeutics ,Federal Circuit ,Patent Trial ,Appeal Board ,Final Written Decision ,Ocular Therapeutix ,Mati Therapeutic ,Patent Owner ,Owner Mati ,Petitioner Ocular ,Intl Inc ,Johnston Assocs ,Legal ,Business ,Litigation ,Patent ,Patent Law ,P ,Tab ,Intellectual Property ,